• There are no suggestions because the search field is empty.

Careers    Developers    Support     日本語

Glioblastoma Multiforme 
Trial Solutions

Enhancing study success with advanced clinical research technologies and expert solutions for GBM trials.

DOWNLOAD BROCHURE GET IN TOUCH

Effective solutions for GBM research

With numerous barriers limiting progress in drug development for glioblastoma multiforme (GBM), it remains an area with few effective therapeutic options. Your GBM research program represents hope to millions of patients living with this rare neuro-oncological disease. Signant SmartSignals solutions can address specific research challenges so you can deliver new and better treatment options.

Why Signant Health

  • Capture Better COA Data
  • Increase Ratings Accuracy
  • Streamline Consent & Reconsent
  • Minimize Patient Burden
  • Gain Operational Efficiency
  • Assess Cognitive Function
  • Capture Better COA Data

    Capture Better COA Data

    Capture high quality assessment data to support your GBM study endpoints with an eCOA platform designed for the complexities of oncology research. With pre-validated library instruments and study design templates, you can launch significantly faster. Our clinical science and operations experts support your study team from launch to closeout.
     

  • Increase Ratings Accuracy

    Increase Ratings Accuracy

    Ensure that the raters and investigative staff administer assessments or measures in your GBM study correctly and consistently. Our Rater Training program can be customized to cover performance outcomes, cognitive assessments, or even sensors and wearables, improving the reliability of the data these measures generate.
     

  • Streamline Consent & Reconsent

    Streamline Consent & Reconsent

    Choose any of our tiered eConsent solutions to help convey complex information about the disease and study to patients without the burden of travel. We manage multiple consents common in oncology studies, ensuring up-to-date ICFs and limiting the risk of inspection findings.

  • Minimize Patient Burden

    Minimize Patient Burden

    Reducing the need for travel eases a major burden of clinical trial participation for GBM patients. Leverage our multifunctional Telemedicine platform to monitor patients, offer them a virtual walk-in clinic, as well as keep them enrolled and adherent. This platform caters to patients', sites', and sponsors' needs alike.
     

  • Gain Operational Efficiency

    Gain Operational Efficiency

    Signant’s RTSM system utilizes unique algorithms to implement intricate randomization schemes rapidly as well as optimize product usage and efficiency. Our system and dedicated team help you launch faster, manage mid-study changes with ease, and support trial operations no matter how or where you conduct research.
     

  • Assess Cognitive Function

    Assess Cognitive Function

    Evaluate the impact of GBM and treatments on patients' cognitive function throughout your study with our computerized battery of Cognitive Assessments. Highly sensitive and designed for repeated use, it has been used extensively in both CNS and oncology trials to detect impairments and improvements in cognitive function.

Comprehensive GBM experience

0

STUDIES

0

PATIENTS

0

COUNTRIES

0

SITES

Explore our GBM trial resources
SOLUTION BROCHURE

GBM Trial Solutions Overview


GET INSIGHTS
VIDEO

GBM Trial Solutions


WATCH [2 MIN]
SOLUTION

CNS Clinical Trial Solutions

 
LEARN MORE

eClinical solutions for GBM trials

Ready to learn more?

Discover how Signant can support your current or upcoming GBM trials. 

DOWNLOAD BROCHURE GET STARTED